Cambium Networks (NASDAQ:CMBM) reported quarterly earnings of $0.01 per share which missed the analyst consensus estimate of $0.02 by 50 percent. This is a 97.56 percent decrease over earnings of $0.41 per share from the
Companies Reporting Before The Bell
• Mirum Pharmaceuticals (NASDAQ:MIRM) is expected to report quarterly loss at $1.34 per share on revenue of $8.46 million.
Cambium Networks now expects GAAP revenues of between $61-$63 million compared to the previous outlook of $77.5-$81.5 million provided on February 17, 2022. The changeCambium Networks now expects GAAP revenues of between $61-$63 million compared to the previous outlook of $77.5-$81.5 million provided on February 17, 2022.